Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPU12.L Regulatory News (PU12)

  • There is currently no data for PU12

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Report

30 Nov 2017 09:42

RNS Number : 9743X
Puma VCT 12 PLC
30 November 2017
 
 Puma VCT 12 plc

Interim Report

 

For the period ended 31 August 2017

 

 

Officers and Professional Advisers

 

 

Directors

Auditor

Raymond Pierce (Chairman)

Jim Brydie (resigned on 01.11.2017)

David Brock (appointed on 01.11.2017)

Graham Shore

 

RSM UK Audit LLP

Chartered Accountants

25 Farringdon Street

London EC4A 4AB

Secretary

Eliot Kaye

 

Registered Number

09758309

 

 

Sponsors and Solicitors

Howard Kennedy

No 1 London Bridge

London SE1 9BG

 

Registered Office

Bond Street House

14 Clifford Street

London W1S 4JU

 

 

Investment Manager

Puma Investment Management Limited

Bond Street House

14 Clifford Street

London W1S 4JU

 

Bankers

Metro Bank plc

One Southampton Row

London

WC1B 5HA

 

VCT Tax Advisor

PricewaterhouseCoopers LLP

1 Embankment Place

London WC2N 6RH

Registrar

SLC Registrars

42-50 Hersham Road

Walton-on-Thames

Surrey

KT12 1RZ

 

Custodian

Howard Kennedy

No 1 London Bridge

London SE1 9BG

 

Administrator

PI Administration Services Limited

Bond Street House

14 Clifford Street

London W1S 4JU

 

 

 

 

Chairman's Statement

 

Highlights 

 

· 95% of fund invested in a diverse range of high quality businesses and projects

· Qualifying investments now represent just under 60% of the fund, following investments made in eight SMEs since the period end

· NAV per share up 0.24p in the half year at 95.62p

 

Introduction

 

I am pleased to present the interim report for Puma VCT 12 plc (the 'Company') for the period to 31 August 2017. As at the date of reporting, 95% of funds raised have been invested in a diverse range of high quality businesses and projects. Since the period end, the Company has completed eight qualifying investments into small and medium sized businesses ("SMEs"), representing just under 60% of the fund. Our portfolio is well positioned to deliver attractive returns to shareholders within its expected time horizon.

 

Net Asset Value ('NAV')

 

The NAV per share at the period end was 95.62p, including a profit for the period of £74,000 which represents a return of 0.24p per ordinary share during the period. The Company's total net assets at the period end were just over £29.5 million.

 

Investments

 

Qualifying Investments

 

Growing Fingers - Children's Nursery

As reported in the Company's previous annual report, the Company had made a £294,000 qualifying investment (as part of a £2.8 million investment alongside other Puma VCTs) in Growing Fingers Limited, and a further £126,000 was invested during the period. The investment is funding the construction and launch of a new purpose-built 108 place nursery school in Wendover, Buckinghamshire, an affluent commuter town with direct links to London. Growing Fingers is a new venture headed by a management team with many years' operational experience in nurseries and healthcare facilities. The Company benefits from first charge security over the Wendover site and the Growing Fingers business.

 

The Company has completed eight new qualifying investments since the period end, details of which are as follows.

 

Signal Building Services - Construction projects

In September 2017, the Company invested £200,000 (as part of a total investment round of £2 million) into Signal Building Services Limited, a recently established business specialising in delivering turnkey solutions to construction projects. The management team have over 40 years' of combined experience in the construction sector and we understand that they are in advanced negotiations to commence their first project.

 

Knott End - Pubs with Microbreweries

The Company invested £2.4 million (as part of a £4.8 million qualifying investment alongside another Puma VCT) in Knott End Limited which has entered into a franchise agreement with Brewhouse & Kitchen Limited to roll out a portfolio of pubs offering on-site craft micro-brewing activities and good quality food. The management team at Knott End have already identified several possible locations for their first unit and expect to open their first pub early next year.

 

Sweat Union - Budget Gyms

In November 2017, the Company invested £3.35 million (as part of a total investment round of £3.75 million) into Sweat Union Limited, an innovative fitness business in the budget gym space. The high calibre management team includes Frank Reed, a co-founder of Virgin Active, as CEO and has already opened five gyms under the Sweat! brand. Sweat! is pitched at a slight price premium to budget rivals, has dedicated spinning and aerobics studios and recently unveiled a partnership with Debenhams to launch in-store gyms. The Company's investment will facilitate the roll-out of the brand across the United Kingdom.

 

Sunlight Education Nucleus - Special Educational Needs Schools

In November 2017, the Company made a £2.35 million qualifying investment (as part of a £4.7 million investment alongside other Puma VCTs) in Sunlight Education Nucleus Limited, a company seeking to develop, own and operate a series of special education needs schools across the United Kingdom.

 

Pure Cremation - Crematorium and Direct Cremations

In November 2017, the Company invested £3 million in Pure Cremation Holdings Limited (as part of a £5 million qualifying investment alongside another Puma VCT). Pure Cremation is a leading provider of so-called direct cremations, meeting the needs of a growing number of people in the United Kingdom who want a respectful direct cremation arranged without any funeral, leaving them free to say farewell how, where and when is right for them. The Pure Cremation team have many years' experience in the funeral services sector and have secured an option over a site near Andover on which they will seek to develop a new crematorium and central facility.

 

Children's Nurseries

 

We are pleased to have completed qualifying investments in three children's day nursery businesses, backing experienced management teams, details of which are as follows.

 

Applebarn Nurseries

In October 2017, the Company invested £1.1 million in Applebarn Nurseries Limited (as part of a £2.2 million qualifying investment alongside another Puma VCT) which is developing and will operate a new 120 place children's day nursery in Altrincham, South Manchester. The management team behind Applebarn include Stewart Pickering (the founder of Kidsunlimited which he built up to 50 nurseries before a successful exit) and experienced developer and contractor, the McGoff Group. The nursery is expected to open in the third quarter of 2018.

 

Kid and Play

The Company made a £1.7 million qualifying investment in Kid and Play Limited, alongside funds invested by another Puma VCT totalling £3.4 million, in October 2017. Kid and Play is seeking to develop, own and operate a new children's day nursery and has identified a first site in Bromley, South London.

 

South West Cliffe

In October 2017, the Company invested £2.1 million (as part of a £4.2 million qualifying investment alongside another Puma VCT) in South West Cliffe Limited, supporting an experienced management team to roll out a portfolio of purpose built day nurseries.

 

Non-Qualifying Investments

 

As previously reported, the Company had initially invested just under £22 million in a series of lending businesses offering an appropriate risk adjusted return in the short to medium term. It was intended that these positions would be liquidated in due course as the Company makes qualifying investments. Details of the loans that these lending businesses have made, many of which were repaid in full during the period to facilitate the qualifying investments referred to above, are set out below.

 

Portfolio of freehold ground rent interests

In June 2016, a £2.3 million loan was advanced and secured against a portfolio of freehold assets and the associated ground rents, as part of a package from other vehicles managed and advised by the Investment Manager totalling £4.3 million. We are pleased to report that, during the period, the loan was repaid in full giving a good rate of return.

 

Construction of Airport Hotel, Edinburgh

During the period, a £1.6 million loan (as part of an overall facility of £13.5 million) was agreed with Ability Hotels (Edinburgh) Limited to fund the development of a new 175-room Hampton by Hilton hotel at Edinburgh Airport. The hotel is scheduled to open in the summer of 2019 at which time it will be the newest and nearest hotel to the airport terminal building. The Ability Group is an experienced developer and operator of hotels and the loan is secured with a first charge over the site. Following the period end, Ability obtained planning permission to increase the number of rooms to 240 and the overall facility is anticipated to increase accordingly to £17.75 million.

 

Rovex Business Park, Birmingham

In July 2016, a loan of £1.5 million, together with loans from other vehicles managed and advised by your Investment Manager totalling £2.5 million, was advanced to Pall Mall Investments 2016 Limited. The loan was used to acquire Rovex Business Park, an industrial business park in Birmingham. We are pleased to report that, shortly following the period end, the loan was repaid in full giving a good rate of return.

 

Pharmacy, Notting Hill

A loan of £1.03 million was advanced to Zinbake Limited to facilitate the acquisition of the assets of a pharmacy business located on Portobello Road in Notting Hill, London. The borrower is an experienced operator and has carried out an extensive refurbishment program at the new unit which has a good mix of NHS and over-the-counter income. The loan is secured with a first charge on the new pharmacy business and a first charge over the borrower's existing pharmacy located in south west London, both of which are trading well.

 

Citrus Group

As previously reported, a series of loans totalling £1 million were advanced to various entities within the Citrus Group. These loans, together with loans from other vehicles managed and advised by the Investment Manager, form part of a series of revolving credit facilities to provide working capital to the Citrus PX business. Citrus PX operates a property part exchange service facilitating the rapid purchase of properties for developers and homeowners. The facility provides a series of loans to Citrus PX, with the benefit of a first charge over a geographically diversified portfolio of residential properties on conservative terms.

 

Ironbridge Group

We previously reported that a £800,000 million facility (as part of a total facility of £5 million) had been advanced to an entity within the Ironbridge Group, providing the senior 70% slice of "stretched senior" bridging loans on non-owner-occupied properties in London and the South East with Ironbridge funding the subordinated 30% slice. Ironbridge operate a bridge lending business and have successfully deployed over £50m of customer loans to date. Loans are being advanced from 6 to 24 months with the senior slice at a conservative loan-to-value ratio.

 

Mixed Residential Commercial Development, Tower Bridge

A £1.8 million loan (together with loans from other vehicles managed and advised by the Investment Manager totalling £4.3 million) was advanced to Empire TBR Limited to fund the construction of a mixed residential and commercial development near Tower Bridge, London. The location is well suited to the target market, with good transport links and local amenities, and the developer has successfully completed several similar redevelopments in central London. Unfortunately, the project has made little progress since the loan was advanced and may well not proceed to development. However, the loan is secured with a first charge over the site and the security covers the loan exposure.

 

Mixed Residential Commercial Development, Bloomsbury

As previously reported, a £3.9 million loan (as part of a total facility of £17.97 million, increased from £17.5 million) was advanced to Cudworth Limited to fund the construction of a mixed residential and commercial development in Bloomsbury, London, close to the British Museum and 600m from King's Cross station. The development includes 11 apartments, 2 houses and 11,800 square feet of B1 commercial space. The loan is secured with a first charge over the site.

 

Care Home for the Elderly, Chester

A £608,000 loan (as part of an overall facility of £7.4 million) was advanced to New Care (Chester) Limited to fund the development and initial trading of a 77-bed purpose-built care home in Chester. The New Care Group is an experienced developer and operator of care homes. The New Care Group is an experienced developer and operator of care homes. The loan is secured with a first charge over the site and is expected to generate an attractive return. We understand that the development is progressing well and the care home is scheduled to open in the first quarter of 2018.

 

Liquidity Management

To further manage liquidity, the Company holds £1.2 million in a floating rate note issued by Royal Bank of Canada and £1.2 million in a floating rate note issued by Commonwealth Bank of Australia. It is intended that these positions will be liquidated in due course as the Company makes further qualifying investments.

 

VCT Qualifying Status

 

PricewaterhouseCoopers LLP ('PwC') provides the board and the investment manager with advice on the ongoing compliance with Her Majesty's Revenue & Customs ('HMRC') rules and regulations concerning VCTs. PwC assists the Investment Manager in establishing the status of investments as qualifying holdings and has reported that the Company has met all HMRC's criteria to date. PwC will continue to assist the Investment Manager in monitoring rule compliance.

 

Principal risks and uncertainties

 

Although the economy in the UK continues to grow, there are some signs of a slowdown associated with high personal debt levels and low growth in real wages. The consequences of this for the Company's investment portfolio constitute the principal risk and uncertainty for the Company in the second half of the year.

 

Patient Capital Review

 

We are pleased that, in its response to the Financing Growth in Innovative Firms Consultation published with the Autumn Budget on 22 November 2017 ("the Patient Capital Review"), the Government has recognised the continuing importance of VCTs in providing much needed investment in SMEs. We note that proposed changes arising out of the Patient Capital Review include increasing VCTs' minimum qualifying investment percentage threshold from 70% to 80% with effect from 6 April 2019. As reported above, the Company has made good progress in making qualifying investments and we therefore believe that it is on track to meet this target.

 

Board changes

 

The Company announced on 1 November 2017 that Jim Brydie had resigned as a director with immediate effect. I would like to take this opportunity to thank Jim for his valuable contribution to the Company since its launch and wish him well for the future. We also announced that David Brock was appointed as director of the Company from the same date. David was previously a director of the first four Puma VCTs and, most recently, a director of Puma VCT 8 plc which has, to date, paid out 70p per share in dividends to shareholders. He was, until July 1997, a main board director of MFI Furniture Group plc and Managing Director of MFI International Limited having been involved at a senior level in both MFI's management buy-out and its subsequent flotation. He started his career at Marks and Spencer Group PLC. David is currently Chairman of Episys Limited, Elderstreet VCT plc and a non- executive director of Hargreave Hale AIM VCT 1 plc. He has had interests in venture capital both as a private investor and as an adviser to various funds

 

Outlook

 

We are pleased that a substantial proportion of the Company's available cash is now invested in a diverse portfolio of qualifying and non-qualifying investments, generating an attractive return. The Investment Manager is in legal process with a number of further qualifying investment opportunities and expects to make such investments in the second half of the year. There are many suitable companies which are well-managed, in good market positions and which need our investment. We therefore believe the Company is strongly positioned to continue to assemble a portfolio to deliver attractive returns to shareholders.

 

 

 

Ray Pierce

Chairman

30 November 2017

 

 

 

Income Statement (unaudited)

For the period ended 31 August 2017

 

 

 

Period ended 31 August 2017

Period ended 31 August 2016

Period ended 28 February 2017

 

Note

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

 

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Gains on investments

 

-

7

7

-

4

4

-

26

26

Income

 

487

-

487

93

-

93

477

-

477

 

 

 

 

 

 

 

 

 

 

 

 

 

487

7

494

93

4

97

477

26

503

 

 

 

 

 

 

 

 

 

 

 

Investment management fees

4

(74)

(222)

(296)

(71)

(213)

(284)

(144)

(432)

(576)

Other expenses

 

(124)

-

(124)

(157)

-

(157)

(297)

-

(297)

 

 

 

 

 

 

 

 

 

 

 

 

 

(198)

(222)

(420)

(228)

(213)

(441)

(441)

(432)

(873)

 

 

 

 

 

 

 

 

 

 

 

Return/(loss) on ordinary activities before taxation

 

289

(215)

74

(135)

(209)

(344)

36

(406)

(370)

Tax on return on ordinary activities

 

-

-

-

-

-

-

(7)

7

-

 

 

 

 

 

 

 

 

 

 

 

Return/(loss) on ordinary activities after tax attributable to equity shareholders

 

289

(215)

74

(135)

(209)

(344)

29

(399)

(370)

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

 

 

 

 

 

 

 

 

Return/(loss) per Ordinary Share (pence)

2

0.93p

(0.70p)

0.24p

(0.44p)

(0.68p)

(1.11p)

0.14p

(1.98p)

(1.84p)

 

 

 

The total column of this statement is the profit and loss of the Company. All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

Balance Sheet (unaudited)

As at 31 August 2017

 

Note

As at31 August 2017

As at31 August 2016

As at28 February 2017

 

 

£'000

£'000

£'000

Fixed Assets

 

 

 

 

Investments

6

25,793

24,826

27,129

 

 

 

 

 

Current Assets

 

 

 

 

Prepayments

 

942

83

458

Cash

 

2,985

4,731

2,060

 

 

3,927

4,814

2,518

Creditors - amounts falling due within one year

 

(164)

(132)

(165)

 

 

 

 

 

Net Current Assets

 

3,763

4,682

2,353

 

 

 

 

 

 

 

 

 

 

Net Assets

 

29,556

29,508

29,482

 

 

 

 

 

Capital and Reserves

 

 

 

 

Called up share capital

 

19

19

19

Share premium account

 

29,833

29,833

29,833

Capital reserve - realised

 

(620)

(213)

(425)

Capital reserve - unrealised

 

6

4

26

Revenue reserve

 

318

(135)

29

 

 

 

 

 

Equity Shareholders' Funds

 

29,556

29,508

29,482

 

 

 

 

 

 

 

 

 

 

Net Asset Value per Ordinary Share

3

95.62p

95.47p

95.38p

 

 

 

 

 

Diluted Net Asset Value per Ordinary Share

3

95.62p

95.47p

95.38p

Cash Flow Statement (unaudited)

For the period ended 31 August 2017

 

 

Period ended 31 August 2017

Period ended 31 August 2016

Period ended 28 February 2017

 

£'000

£'000

£'000

 

 

 

 

Operating activities

 

 

 

Loss on ordinary activities after tax

74

(344)

(370)

Gains on investments

(7)

(4)

(26)

Increase in debtors

(484)

(83)

(458)

Increase in creditors

(1)

132

165

 

 

 

 

Net cash used in operating activities

(418)

(299)

(689)

 

 

 

Cash flow from investing activities

 

 

 

Purchase of investments

1,343

(24,822)

(27,103)

 

 

 

 

Net cash used in investing activities

1,343

(24,822)

(27,103)

 

 

 

 

Cash flow from financing activities

 

 

 

Proceeds received from issue of ordinary share capital

-

30,909

30,909

Expenses paid for issue of share capital

-

(1,057)

(1,057)

Proceeds received from issue of redeemable preference shares

-

13

13

Redemption of redeemable preference shares

-

(13)

(13)

 

 

 

 

Net cash generated from financing activities

-

29,852

29,852

 

 

 

 

Increase in cash

925

4,731

2,060

Net cash at start of the period

2,060

-

-

 

 

 

 

Net funds at the period end

2,985

4,731

2,060

 

 

Reconciliation of Movements in Shareholders' Funds (unaudited)

For the period ended 31 August 2017

 

 

Called up share capital

Share premium account

Capital reserve - realised

Capital reserve - unrealised

Revenue reserve

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

Shares issued in the period

19

30,890

-

-

-

30,909

Expense of share issue

-

(1,057)

-

-

-

(1,057)

Total recognised (losses)/gains for the period

-

-

(213)

4

(135)

(344)

 

 

 

 

 

 

 

Balance as at 31 August 2016

19

29,833

(213)

4

(135)

29,508

 

 

 

 

 

 

 

Total recognised (losses)/gains for the period

-

-

(212)

22

164

(26)

 

 

 

 

 

 

 

Balance as at 28 February 2017

19

29,833

(425)

26

29

29,482

 

 

 

 

 

 

 

Total recognised (losses)/gains for the period

-

-

(195)

(20)

289

74

 

 

 

 

 

 

 

Balance as at 31 August 2017

19

29,833

(620)

6

318

29,556

 

Notes to the Interim Report

For the period ended 31 August 2017

 

1. Accounting Policies

 

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of fixed asset investments, and in accordance with applicable Accounting Standards and with the Statement of Recommended Practice, "Financial Statements of Investment Trust Companies and Venture Capital Trusts" ("SORP") and in accordance with the Financial Reporting Standard 102 ("FRS102").

 

2. Return per Ordinary Share

 

The total profit per share of 0.24p is based on the loss for the period of £74,000 and the weighted average number of shares in issue as at 31 August 2017 of 30,909,188 calculated from the date of the first receipt of proceeds from the issue of ordinary share capital.

 

3. Net asset value per share

 

As at31 August 2017

As at31 August 2016

As at28 February 2017

Net assets

29,556,000

29,508,000

29,482,000

Shares in issue

30,909,188

30,909,188

30,909,188

Net asset value per share

Basic

95.62p

95.47p

95.38p

Diluted

95.62p

95.47p

95.38p

 

 

 

4. Management fees

 

The Company pays the Investment Manager an annual management fee of 2% of the Company's net assets. The fee is payable quarterly in arrears. The annual management fee is allocated 75% to capital and 25% to revenue.

 

 

5. The financial information for the period ended 31 August 2017 has not been audited and does not comprise full financial statements within the meaning of Section 423 of the Companies Act 2006. The interim financial statements have been prepared on the same basis as will be used to prepare the annual financial statements.

 

 

 

 

 

 

Notes to the Interim Report continued

For the period ended 31 August 2017

 

 

6. Investment portfolio summary

 

Valuation

Cost

Gain/(loss)

Valuation as a % of Net Assets

As at 31 August 2017

£'000

£'000

£'000

 

 

 

 

 

 

Qualifying Investment - Unquoted

 

 

 

 

Growing Fingers Limited

420

420

-

1%

 

 

 

 

 

Total Qualifying Investments 1

420

420

-

1%

 

 

 

 

 

Non-Qualifying Investments

 

 

 

 

Piccadilly Lending Limited

2,400

2,400

-

8%

Bayswater Lending Limited

1,900

1,900

-

6%

Victoria Lending Limited

3,800

3,800

-

13%

Tottenham Lending Limited

3,800

3,800

-

13%

Sloane Lending Limited

3,800

3,800

-

13%

Marble Lending Limited

3,800

3,800

-

13%

Valencia Lending Limited

2,441

2,441

-

8%

 

 

 

 

 

Total Non-Qualifying investments

21,941

21,941

-

74%

 

 

 

 

 

Liquidity Management Investments

 

 

 

 

Royal Bank of Canada Bond 2

2,213

2,213

-

7%

Commonwealth Bank of Australia Bond 2

1,219

1,213

6

4%

 

 

 

 

 

Total Liquidity Management Investments

3,432

3,426

6

11%

 

 

 

 

 

Total Investments

25,793

25,787

6

86%

Balance of Portfolio

3,763

3,763

 

14%

 

 

 

 

 

Net Assets

29,556

29,550

6

100%

 

 

1 As discussed in the Chairman's statement, a substantial number of qualifying investments were made following the period end, such that just under 60% of the portfolio on the HMRC basis is now qualifying.

 

2 Quoted investment listed on the London Stock Exchange

 

Of the investments held at 31 August 2017, all are incorporated in England and Wales with the exception of the liquidity management holdings.

 

Copies of this Interim Statement will be made available on the website: http://www.pumainvestments.co.uk/pages/view/investors-information-vcts

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EANFEDDNXFEF
12
Date   Source Headline
23rd Jun 20223:14 pmRNSResult of General Meeting
23rd Jun 20227:30 amRNSStatement re. Suspension
25th May 20227:00 amRNSDividend, Proposed Liquidation & Notice of Meeting
12th May 20229:59 amRNSDisposal of stake in Sunlight Education Nucleus
3rd May 20229:39 amRNSDisposal of stake in Tictrac Limited
28th Feb 20224:26 pmRNSTotal Voting Rights
23rd Feb 20225:34 pmRNSTransaction in Own Shares
19th Nov 202110:28 amRNSHalf-year Report
31st Aug 202112:18 pmRNSResults of AGM
25th Aug 20217:00 amRNSDividend Declaration
3rd Aug 202112:08 pmRNSNotice of AGM
30th Jun 20214:40 pmRNSAnnual Financial Report
21st Jun 202111:36 amRNSDisposal
15th Mar 20212:06 pmRNSNotification of Major Holdings
15th Mar 20212:01 pmRNSNotification of Major Holdings
18th Dec 20202:12 pmRNSDividend Declaration
26th Nov 202010:17 amRNSHalf-year Report
24th Aug 202011:45 amRNSResult of AGM
13th Aug 202012:33 pmRNSSuspension of Monthly NAV Release
29th Jul 20204:02 pmRNSNotice of AGM
29th Jun 20208:00 amRNSAnnual Financial Report
3rd Mar 20202:35 pmRNSNet Asset Value(s)
20th Feb 20203:02 pmRNSDividend Declaration
28th Jan 20203:06 pmRNSNet Asset Value(s)
20th Dec 20199:38 amRNSNet Asset Value(s)
28th Nov 201910:13 amRNSNet Asset Value(s)
26th Nov 201912:52 pmRNSHalf-year Report
28th Oct 20192:17 pmRNSNet Asset Value(s)
26th Sep 201912:07 pmRNSNet Asset Value
6th Sep 201911:15 amRNSNet Asset Value(s)
28th Aug 20193:00 pmRNSResult of AGM
6th Aug 20192:41 pmRNSAnnual Financial Report
1st Aug 201910:13 amRNSNet Asset Value(s)
28th Jun 20199:47 amRNSNet Asset Value(s)
6th Jun 201911:08 amRNSNet Asset Value(s)
8th May 20192:07 pmRNSNet Asset Value(s)
8th May 20192:05 pmRNSNet Asset Value(s)
1st May 20196:19 pmRNSPuma VCT 12 plc: Holding in Sweat Union Limited
28th Feb 20199:30 amRNSNet Asset Value(s)
1st Feb 201910:35 amRNSNet Asset Value(s)
28th Dec 20181:41 pmRNSNet Asset Value(s)
30th Nov 20181:18 pmRNSHalf-year Report
30th Nov 201812:46 pmRNSNet Asset Value(s)
29th Oct 201810:41 amRNSNet Asset Value(s)
28th Sep 20187:00 amRNSNet Asset Value(s)
30th Aug 201811:01 amRNSNet Asset Value(s)
24th Aug 20183:26 pmRNSDividend Declaration - Correction
8th Aug 20183:58 pmRNSResults of AGM
25th Jul 20186:12 pmRNSNet Asset Value(s)
12th Jul 20184:16 pmRNSAnnual Financial Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.